These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19483322)

  • 1. Active uptake of ulifloxacin from plasma to lung that controls its concentration in epithelial lining fluid.
    Aoki M; Iguchi M; Hayashi H; Shibasaki S; Kurosawa T; Hayashi M
    Biol Pharm Bull; 2009 Jun; 32(6):1095-100. PubMed ID: 19483322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposal of membrane transport mechanism of protein-unbound ulifloxacin into epithelial lining fluid determined by improved microdialysis.
    Aoki M; Iguchi M; Hayashi H; Suzuki H; Shibasaki S; Kurosawa T; Hayashi M
    Biol Pharm Bull; 2008 Sep; 31(9):1773-7. PubMed ID: 18758075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transporter-mediated hepatic uptake of ulifloxacin, an active metabolite of a prodrug-type new quinolone antibiotic prulifloxacin, in rats.
    Yagi Y; Aoki M; Iguchi M; Shibasaki S; Kurosawa T; Kato Y; Tsuji A
    Drug Metab Pharmacokinet; 2007 Oct; 22(5):350-7. PubMed ID: 17965518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of orally administered prulifloxacin into human lung tissue.
    Concia E; Allegranzi B; Ciottoli GB; Orticelli G; Marchetti M; Dionisio P
    Clin Pharmacokinet; 2005; 44(12):1287-94. PubMed ID: 16372826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation among the toxicity profiling (28-days repeated oral dose toxicity), toxicokinetics and tissue distribution data of ulifloxacin, the active metabolite of prulifloxacin in Wistar albino rats.
    Nandi U; Roy B; Das AK; Pal TK
    Environ Toxicol Pharmacol; 2012 Sep; 34(2):588-607. PubMed ID: 22885677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution characteristics of orally administered olamufloxacin, a newly synthesized fluoroquinolone antibacterial, in lung epithelial lining fluid and alveolar macrophage in rats.
    Sun J; Deguchi Y; Tauchi Y; He Z; Cheng G; Morimoto K
    Eur J Pharm Biopharm; 2006 Oct; 64(2):238-45. PubMed ID: 16875808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 1. Ciprofloxacin, moxifloxacin, and grepafloxacin.
    Gontijo AV; Brillault J; Grégoire N; Lamarche I; Gobin P; Couet W; Marchand S
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3942-9. PubMed ID: 24798283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution characteristics of clarithromycin and azithromycin, macrolide antimicrobial agents used for treatment of respiratory infections, in lung epithelial lining fluid and alveolar macrophages.
    Togami K; Chono S; Morimoto K
    Biopharm Drug Dispos; 2011 Oct; 32(7):389-97. PubMed ID: 21812004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penetration of orally administered prulifloxacin into human prostate tissue.
    Giberti C; Gallo F; Rosignoli MT; Ruggieri A; Barattè S; Picollo R; Dionisio P
    Clin Drug Investig; 2009; 29(1):27-34. PubMed ID: 19067472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration of Ciprofloxacin and Amikacin into the Alveolar Epithelial Lining Fluid of Rats with Pulmonary Fibrosis.
    Ni W; Yang D; Mei H; Zhao J; Liang B; Bai N; Chai D; Cui J; Wang R; Liu Y
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transport characteristics of clarithromycin, azithromycin and telithromycin, antibiotics applied for treatment of respiratory infections, in Calu-3 cell monolayers as model lung epithelial cells.
    Togami K; Chono S; Morimoto K
    Pharmazie; 2012 May; 67(5):389-93. PubMed ID: 22764569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Insights on the Pharmacokinetics of Ulifloxacin After Administration of Prulifloxacin in Patients with Mild, Moderate and Severe Renal Impairment.
    Tellone V; Coppola P; Ammendola M; Di Loreto G; Picollo R; Del Vecchio A; Comandini A; Garofolo F; Tongiani S
    Drugs R D; 2018 Sep; 18(3):237-245. PubMed ID: 30151791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a liquid chromatography-tandem mass spectrometry method to determine ulifloxacin, the active metabolite of prulifloxacin in rat and rabbit plasma: application to toxicokinetic study.
    Roy B; Choudhury H; Das A; Das AK; Pal TK
    Biomed Chromatogr; 2011 Aug; 25(8):890-901. PubMed ID: 21154639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of marbofloxacin within the bronchoalveolar region of healthy pigs.
    Ijiri M; Ishikawa S; Jibiki Y; Miyazawa M; Senokuchi A; Hobo S
    J Vet Med Sci; 2020 Aug; 82(8):1080-1083. PubMed ID: 32565495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the active metabolite of prulifloxacin in human plasma by liquid chromatography-tandem mass spectrometry.
    Guo L; Qi M; Jin X; Wang P; Zhao H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Mar; 832(2):280-5. PubMed ID: 16490405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of marbofloxacin in the bronchoalveolar region in healthy calves.
    Hayashi J; Otomaru K; Hirata M; Ishikawa S; Ikedo T; Horinouchi C; Kuramae T; Tsumagari K; Hobo S
    J Vet Med Sci; 2019 May; 81(5):730-733. PubMed ID: 30918227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady-state intrapulmonary concentrations of moxifloxacin, levofloxacin, and azithromycin in older adults.
    Capitano B; Mattoes HM; Shore E; O'Brien A; Braman S; Sutherland C; Nicolau DP
    Chest; 2004 Mar; 125(3):965-73. PubMed ID: 15006955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung tissue distribution after intravenous administration of grepafloxacin: comparative study with levofloxacin.
    Yamamoto H; Koizumi T; Hirota M; Kaneki T; Ogasawara H; Yamazaki Y; Fujimoto K; Kubo K
    Jpn J Pharmacol; 2002 Jan; 88(1):63-8. PubMed ID: 11855679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ozone-reactive absorption by pulmonary epithelial lining fluid constituents.
    Langford SD; Bidani A; Postlethwait EM
    Toxicol Appl Pharmacol; 1995 May; 132(1):122-30. PubMed ID: 7747275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antibacterial agents.
    Rodvold KA; George JM; Yoo L
    Clin Pharmacokinet; 2011 Oct; 50(10):637-64. PubMed ID: 21895037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.